MEGAN MACCARTHY: Open Payments
NPI 1316979248 · DE PERE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,035 in 110 payments from 15 companies in 2025. Trend: 2023 $1,560 · 2024 $2,175 · 2025 $2,035
Food & beverage: $2,035
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $377 |
| ABBVIE INC. | 21 | $286 |
| UCB, Inc. | 13 | $260 |
| Novartis Pharmaceuticals Corporation | 11 | $254 |
| Regeneron Healthcare Solutions, Inc. | 8 | $208 |
| GENZYME CORPORATION | 6 | $136 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $110 |
| Lilly USA, LLC | 4 | $93 |
| PFIZER INC. | 3 | $70 |
| Incyte Corporation | 3 | $57 |
Products named: TREMFYA, DUPIXENT, Bimzelx, COSENTYX, RINVOQ, SKYRIZI, BLU-U, TALTZ.
Industry payments across WI — which companies pay providers there.
